New Journey Health Technology GroupLTD Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	1.7yrs

Recent management updates

Recent updates

New Journey Health Technology GroupLTD's (SZSE:002219) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 24

CEO

New Journey Health Technology GroupLTD has no CEO, or we have no data on them.

Board Members

Name	Position	Tenure	Compensation	Ownership
Lihua Song	Executive VP & Non-Independent Director	1.7yrs	CN¥1.01m	1.07% CN¥ 90.3m
Yanglin Lin	Chairman	3.2yrs	CN¥36.80k	0.76% CN¥ 64.2m
Jun Pu	Independent Director	3.2yrs	CN¥77.90k	no data
Zeyu Tong	Non-Independent Director	3.2yrs	CN¥36.80k	no data
Haitao Li	Chairman of the Supervisory Board	3.2yrs	no data	no data
Ziqing Zhou	Non-Independent Director	1.7yrs	CN¥10.40k	0.20% CN¥ 17.0m
Hengye Guan	Non-Independent Director	1.7yrs	CN¥10.40k	0.029% CN¥ 2.5m
Minggui Xu	Non-Independent Director	1.7yrs	CN¥10.40k	0.029% CN¥ 2.5m
Chenguang Du	Independent Director	1.7yrs	CN¥20.80k	0.0029% CN¥ 244.3k
Jingmin Wang	Independent Director	1.7yrs	CN¥20.80k	0.0041% CN¥ 345.4k
Yanling Zhang	Non-Independent Director	less than a year	no data	0.15% CN¥ 12.3m
Yiting Chi	Independent Director	less than a year	no data	no data

1.7yrs

Average Tenure

42yo

Average Age

Experienced Board: 002219's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

New Journey Health Technology GroupLTD Management

Management criteria checks 0/4

Key information

Recent management updates

New Journey Health Technology Group Co.,LTD, Annual General Meeting, May 10, 2024

New Journey Health Technology Group Co.,LTD Approves Election of Xue Ping as A Non-Independent Director

New Journey Health Technology Group Co.,LTD Approves Board Appointments

High number of new and inexperienced directors

High number of new and inexperienced directors

High number of new and inexperienced directors

Recent updates

First quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.007 in 1Q 2023)

New Journey Health Technology GroupLTD's (SZSE:002219) Sluggish Earnings Might Be Just The Beginning Of Its Problems

New Journey Health Technology Group Co.,LTD, Annual General Meeting, May 10, 2024

Full year 2023 earnings released: EPS: CN¥0.009 (vs CN¥0.048 in FY 2022)

New Journey Health Technology Group Co.,LTD to Report Q1, 2024 Results on Apr 26, 2024

Now 20% overvalued

New Journey Health Technology Group Co.,LTD Approves Election of Xue Ping as A Non-Independent Director

New minor risk - Financial data availability

Now 27% overvalued

Investor sentiment deteriorates as stock falls 17%

New Journey Health Technology Group Co.,LTD to Report Fiscal Year 2023 Results on Apr 18, 2024

Third quarter 2023 earnings released: CN¥0.007 loss per share (vs CN¥0.019 profit in 3Q 2022)

New Journey Health Technology Group Co.,LTD Approves Board Appointments

New major risk - Financial position

Second quarter 2023 earnings released: EPS: CN¥0.011 (vs CN¥0.011 in 2Q 2022)

New Journey Health Technology Group Co.,LTD to Report First Half, 2023 Results on Aug 19, 2023

Full year 2022 earnings released: EPS: CN¥0.048 (vs CN¥0.20 loss in FY 2021)

Hengkang Medical Group Co., Ltd. announced that it expects to receive CNY 685.8 million in funding

High number of new and inexperienced directors

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.019 (vs CN¥0.005 loss in 3Q 2021)

High number of new and inexperienced directors

Hengkang Medical Group Co., Ltd. Announces Executive Appointments

Second quarter 2022 earnings released: EPS: CN¥0.011 (vs CN¥0.001 loss in 2Q 2021)

First quarter 2022 earnings released: EPS: CN¥0.001 (vs CN¥0.025 loss in 1Q 2021)

High number of new and inexperienced directors

Third quarter 2021 earnings released: CN¥0.005 loss per share (vs CN¥0.001 loss in 3Q 2020)

Second quarter 2021 earnings released: CN¥0.001 loss per share (vs CN¥0.009 loss in 2Q 2020)

Full year 2020 earnings released: CN¥0.022 loss per share (vs CN¥1.33 loss in FY 2019)

New 90-day high: CN¥1.97

New 90-day high: CN¥1.94

New 90-day low: CN¥1.54

New 90-day high: CN¥1.84

Third quarter earnings released

First half earnings released

Hengkang Medical Group Co.,Ltd to Report First Half, 2020 Results on Aug 28, 2020

CEO

Board Members

Average Tenure

Average Age